Decreased central μ-opioid receptor availability in fibromyalgia

被引:372
作者
Harris, Richard E.
Clauw, Daniel J.
Scott, David J.
McLean, Samuel A.
Gracely, Richard H.
Zubieta, Jon-Kar
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Mol & Behav Neurosci Inst, Dept Psychiat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA
关键词
fibromyalgia; opioid; pain; chronic; positron emission tomography; mu;
D O I
10.1523/JNEUROSCI.2849-07.2007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The underlying neurophysiology of acute pain is fairly well characterized, whereas the central mechanisms operative in chronic pain states are less well understood. Fibromyalgia (FM), a common chronic pain condition characterized by widespread pain, is thought to originate largely from altered central neurotransmission. We compare a sample of 17 FM patients and 17 age- and sex-matched healthy controls, using mu-opioid receptor (MOR) positron emission tomography. We demonstrate that FM patients display reduced MOR binding potential (BP) within several regions known to play a role in pain modulation, including the nucleus accumbens, the amygdala, and the dorsal cingulate. MOR BP in the accumbens of FM patients was negatively correlated with affective pain ratings. Moreover, MOR BP throughout the cingulate and the striatum was also negatively correlated with the relative amount of affective pain (McGill, affective score/sensory score) within these patients. These findings indicate altered endogenous opioid analgesic activity in FM and suggest a possible reason for why exogenous opiates appear to have reduced efficacy in this population.
引用
收藏
页码:10000 / 10006
页数:7
相关论文
共 44 条
[1]   Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain [J].
Baraniuk, JN ;
Whalen, G ;
Cunningham, J ;
Clauw, DJ .
BMC MUSCULOSKELETAL DISORDERS, 2004, 5 (1)
[2]   Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms [J].
Clauw, DJ ;
Chrousos, GP .
NEUROIMMUNOMODULATION, 1997, 4 (03) :134-153
[3]   Is fibromyalgia a distinct clinical entity? The disapproving rheumatologist's evidence [J].
Cohen, ML .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 1999, 13 (03) :421-425
[4]  
Cook DB, 2004, J RHEUMATOL, V31, P364
[5]  
DANNALS RF, 1985, INT J APPL RADIAT IS, V36, P303, DOI 10.1016/0020-708X(85)90089-4
[6]   State-dependent opioid control of pain [J].
Fields, H .
NATURE REVIEWS NEUROSCIENCE, 2004, 5 (07) :565-575
[7]   COMPARING FUNCTIONAL (PET) IMAGES - THE ASSESSMENT OF SIGNIFICANT CHANGE [J].
FRISTON, KJ ;
FRITH, CD ;
LIDDLE, PF ;
FRACKOWIAK, RSJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (04) :690-699
[8]   INCREASED DENSITY OF MU-OPIOID RECEPTORS IN THE POSTMORTEM BRAIN OF SUICIDE VICTIMS [J].
GABILONDO, AM ;
MEANA, JJ ;
GARCIASEVILLA, JA .
BRAIN RESEARCH, 1995, 682 (1-2) :245-250
[9]  
GEAR RW, 1995, J NEUROSCI, V15, P3154
[10]   The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort [J].
Giesecke, T ;
Gracely, RH ;
Williams, DA ;
Geisser, ME ;
Petzke, FW ;
Clauw, DJ .
ARTHRITIS AND RHEUMATISM, 2005, 52 (05) :1577-1584